Unbalanced replication as a major source of genetic instability in cancer cells - PubMed

Unbalanced replication as a major source of genetic instability in cancer cells

Daniel Corcos. Am J Blood Res. 2012.

Abstract

The origin of genetic instability in tumors is a matter of debate: while the prevailing model postulates a mutator phenotype resulting from an alteration in a caretaker gene as a prerequisite for genetic alterations leading to tumor formation, there is evidence against this model in the majority of cancers. A model for chromosomal instability should take into account the role of oncogenes in directly stimulating DNA and cellular component replication, creating aberrant structures when overexpressed. I will distinguish here two distinct mechanisms for the genetic instability of tumors: primary and secondary. Primary genetic instability is dependent on the inactivation of genes involved in maintaining genetic stability (caretaker genes), whereas secondary genetic instability is dependent on genes involved in tumor progression, i.e. oncogenes and tumor suppressor genes of the gatekeeper type. Secondary genetic instability, the most frequent condition, can be explained by the fact that some of the genes involved in tumor progression control replication of cell structures from within, leading to replication unbalance.

Keywords: DNA replication; Genetic instability; cell replication; chromosomal instability; oncogenes; replication unbalance; tumor suppressor genes; tumorigenesis.

Similar articles

• Molecular biology of colorectal cancer.

  Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Gryfe R, et al. Curr Probl Cancer. 1997 Sep-Oct;21(5):233-300. doi: 10.1016/s0147-0272(97)80003-7. Curr Probl Cancer. 1997. PMID: 9438104 Review.

• Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation.

  Coleman WB, Tsongalis GJ. Coleman WB, et al. Clin Chem. 1995 May;41(5):644-57. Clin Chem. 1995. PMID: 7729041 Review.

• Genomic instability and colon cancer.

  Grady WM. Grady WM. Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):11-27. doi: 10.1023/a:1025861527711. Cancer Metastasis Rev. 2004. PMID: 15000146 Review.

• Genetic instability in human tumors.

  Raptis S, Bapat B. Raptis S, et al. EXS. 2006;(96):303-20. doi: 10.1007/3-7643-7378-4_13. EXS. 2006. PMID: 16383024 Review.

• Potential role of DNA polymerase beta in gene therapy against cancer: a case for colorectal cancer.

  Shadan FF, Villarreal LP. Shadan FF, et al. Med Hypotheses. 1996 Jul;47(1):1-9. doi: 10.1016/s0306-9877(96)90033-x. Med Hypotheses. 1996. PMID: 8819107

Cited by

• Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.

  Hu R, Wang X, Zhan X. Hu R, et al. EPMA J. 2013 Jan 22;4(1):2. doi: 10.1186/1878-5085-4-2. EPMA J. 2013. PMID: 23339750 Free PMC article.

• An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer.

  Sankarapandian V, Venmathi Maran BA, Rajendran RL, Jogalekar MP, Gurunagarajan S, Krishnamoorthy R, Gangadaran P, Ahn BC. Sankarapandian V, et al. Life (Basel). 2022 Jan 2;12(1):59. doi: 10.3390/life12010059. Life (Basel). 2022. PMID: 35054452 Free PMC article. Review.

• Fastest time to cancer by loss of tumor suppressor genes.

  Sanchez-Tapia C, Wan FY. Sanchez-Tapia C, et al. Bull Math Biol. 2014 Nov;76(11):2737-84. doi: 10.1007/s11538-014-0027-7. Epub 2014 Oct 23. Bull Math Biol. 2014. PMID: 25338553 Free PMC article.

• The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe.

  Epstein RJ. Epstein RJ. Front Oncol. 2013 Dec 12;3:304. doi: 10.3389/fonc.2013.00304. Front Oncol. 2013. PMID: 24377088 Free PMC article. Review.

References

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central